VolitionRx Overview

  • Founded
  • 1998
Founded
  • Status
  • Public
  • Employees
  • 50
Employees
  • Stock Symbol
  • VNRX
Stock Symbol
  • Investments
  • 3
  • Share Price
  • $3.28
  • (As of Thursday Closing)

VolitionRx General Information

Description

VolitionRX Ltd is a US-based multi-national life sciences company. It is engaged in developing easy to use blood-based tests to accurately diagnose a range of cancers. The development pipeline includes assays to be used for symptomatic patients or asymptomatic populations. The company has developed more than 30 blood-based assays to detect specific biomarkers. It also develops Nucleosomics tests for several major cancers including CRC, pancreatic, lung and aggressive prostate. In addition, the company engages in the process of developing HyperGenomics tissue and blood-based tests to determine disease subtype following initial diagnosis and to help decide the appropriate therapy.

Contact Information

Website
www.volitionrx.com
Formerly Known As
Standard Capital
Ownership Status
Publicly Held
Financing Status
Corporate Backed or Acquired
Primary Industry
Biotechnology
Other Industries
Other Pharmaceuticals and Biotechnology
Stock Exchange
ASE
Primary Office
  • 1 Scotts Road
  • No 24-05 Shaw Centre
  • Singapore, 228208
  • Singapore
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

VolitionRx Stock Performance

(As of Thursday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$3.28 $3.30 $2.22 - $6.84 $152M 46.7M 647K -$0.43

VolitionRx Financials Summary

In Thousands,
USD 		TTM 30-Jun-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018 FY 2017 31-Dec-2017
EV 171,513 178,301 50,673 66,617
Revenue 23 17 0 0
EBITDA (17,617) (15,182) (17,261) (14,168)
Net Income (18,625) (16,099) (18,009) (14,769)
Total Assets 26,247 21,291 17,489 14,624
Total Debt 3,484 3,938 3,266 2,770
Public Fundamental Data provided by Morningstar, Inc. disclaimer

VolitionRx Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore VolitionRx‘s full profile, request access.

Request a free trial

VolitionRx Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
VolitionRX Ltd is a US-based multi-national life sciences company. It is engaged in developing easy to use blood-based t
Biotechnology
Singapore, Singapore
50 As of 2019
000.00
000000000 000.00

00000000

aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Ex
0000000000 000000000
Alameda, CA
00 As of 0000
000.00
000000000 000.00

000000

ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et do
0000000000000
Minneapolis, MN
00 As of 0000
00.000
0000000000 0 00.000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

VolitionRx Competitors (16)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
OncoCyte Formerly Angel backed Alameda, CA 00 000.00 000000000 000.00
000000 Venture Capital-Backed Minneapolis, MN 00 00.000 0000000000 0 00.000
00000 00000000 Private Equity-Backed Aliso Viejo, CA 000 000000&0
0000000000 Venture Capital-Backed Jerusalem, Israel 00 000.00 00000000000 000.00
00000000 000000000 Venture Capital-Backed Beijing, China 000.00 00000000000 000.00
You’re viewing 5 of 16 competitors. Get the full list »

VolitionRx Executive Team (9)

Name Title Board Seat Contact Info
Cameron Reynolds Chief Executive Officer & Board Member
Gaetan Michel Ph.D Chief Executive Officer
David Vanston Chief Financial Officer, Finance & Chief Accounting Officer, Accounting
Louise Day Chief Marketing & Communications Officer
Jake Micallef Ph.D Chief Scientific Officer
You’re viewing 5 of 9 executive team members. Get the full list »

VolitionRx Board Members (2)

Name Representing Role Since
0000000 00000000 VolitionRx Chief Executive Officer & Board Member 000 0000
000 00000 VolitionRx Board Member 000 0000
To view VolitionRx’s complete board members history, request access »

VolitionRx Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

VolitionRx Investments & Acquisitions (3)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000000 (0000000) 10-Jan-2020 000000000000000000 00000 Drug Delivery 0000000 00000000
000000 00000000000 24-Feb-2015 000000000 00000 00 Buildings and Property 0000000 00000000
Plures Technologies 15-Mar-2011 Merger/Acquisition Application Specific Semiconductors
To view VolitionRx’s complete investments and acquisitions history, request access »

Ready to get started?

Request a free trial

VolitionRx Subsidiaries (1)

Company Name Industry Location Founded
0000000 (0000000) Drug Delivery Gräfelfing, Germany
To view VolitionRx’s complete subsidiaries history, request access »